Johnson & Johnson (J&J) has refocused its generative AI strategy, shifting from broad experimentation to a more targeted approach. Chief Information Officer Jim Swanson explained that this new strategy ensures …
Tag:
AI in drug discovery
{{list.tracks[currentTrack].track_title}}{{list.tracks[currentTrack].track_artist && typeof sonaar_music.option.show_artist_name != 'undefined' ? ' ' + sonaar_music.option.artist_separator + ' ' + list.tracks[currentTrack].track_artist:''}}
{{list.tracks[currentTrack].album_title}}
{{ list.tracks[currentTrack].album_title }}
{{list.tracks[currentTrack].track_title}}
{{list.tracks[currentTrack].track_artist }}
{{classes.speedRate}}X
{{list.tracks[currentTrack].track_title}}
{{list.tracks[currentTrack].track_artist }}